Author: All of Us Badgers

As the Food and Drug Administration and Centers for Disease Control and Prevention repeatedly assure the public that the COVID-19 vaccine will be safe, indications that the review process may be undercut by politics has turned off people in minority communities to getting the vaccine when it becomes available — worrying physicians that communities disproportionately devastated by the pandemic are most at risk of being left out of immunization efforts....

Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19. Preliminary observational studies indicate that convalescent plasma may improve outcomes among severely ill and hospitalized patients with COVID-19....

Many thousands of volunteers from minority groups are needed for huge clinical trials underway or about to begin. Scientists say a diverse group of test subjects is vital to determining whether a vaccine is safe and effective for everyone and instilling broad public confidence in the shots once they become available....

Dr. Elizabeth Burnside and Dr. Jomol Mathew, who are both part of the All of Us Research leadership team at UW-Madison, recently received a National Institutes of Health (NIH) award for a project that will provide the first opportunity at UW to leverage real-time clinical data for research and contribute to the new National #COVID19 Cohort Collaborative, which aims to answer critical research questions to address the pandemic....

While the collection of health data and information has always been part of medicine, advancements in technology have made it easier to compile this information from various sources and parse it out to identify trends. While making sense out of large swaths of information is a difficult task, it’s exactly what Dr. Jomol Mathew was hired to do....

As UW Health and the University of Wisconsin begin scheduling participants for the AstraZeneca COVID-19 vaccine study, experts and leaders are focused on equity and inclusion to ensure a diverse population takes part in this phase 3 clinical trial. A diverse group of participants will give researchers the best understanding on how and if this vaccine works for everyone....

Please Note: All of Us Research Program in-person enrollment is suspended until further notice.

X